ProFibrix's Series B - II Round

ProFibrix raised a round of funding on May 03, 2011.

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting …

Articles about ProFibrix's Series B - II Round: